D3-Pharmacy Aps: Financial statements 2024
CVR: 71087611
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
D3-Pharmacy Aps (CVR 71087611) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -12,310 and a net result of DKK -13,135 compared with DKK -5,594 the year before. Equity in the 2024 report amounted to DKK 530,184. The solvency ratio was 100%.
- Gross Profit
- DKK -12,310
- Profit/Loss
- DKK -13,135
- Equity
- DKK 530,184
- Total Assets
- DKK 530,184
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -12 t. | -13 t. | 530 t. | - |
| 2023 | - | -11 t. | -6 t. | 543 t. | 1 |
| 2022 | - | -10 t. | -18 t. | 549 t. | 1 |
| 2021 | - | -3 t. | -7 t. | 567 t. | 1 |
| 2020 | - | -8 t. | -14 t. | 574 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
D3-Pharmacy Aps has published its annual report for 2023. Gross profit came to DKK -10,995, and the net result was DKK -5,594.
About D3-Pharmacy Aps
D3-Pharmacy Aps is a Danish company of the type Anpartsselskab based in Svenstrup J, founded in 1982. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Finn Jørgen Jensen. The company is owned by Finn Jørgen Jensen. According to the 2023 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,710 and a net result of DKK -4,037 compared with DKK -13,135 the year before. Equity in the 2025 report amounted to DKK 526,147.